Page last updated: 2024-09-04

pomalidomide and African Lymphoma

pomalidomide has been researched along with African Lymphoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, KC; Birsner, AE; D'Amato, RJ; LeBlanc, R; Lentzsch, S; Rogers, MS; Shah, JH; Treston, AM	1
Batchelor, TT; Grommes, C; Nayak, L; Tun, HW	1

Reviews

1 review(s) available for pomalidomide and African Lymphoma

Article	Year
Introduction of novel agents in the treatment of primary CNS lymphoma. Neuro-oncology, 2019, 02-19, Volume: 21, Issue:3 Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Aminopyridines; Antineoplastic Agents, Immunological; Burkitt Lymphoma; Central Nervous System Neoplasms; Humans; Immunologic Factors; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Rituximab; Salvage Therapy; Thalidomide; Toll-Like Receptors; TOR Serine-Threonine Kinases; Tumor Escape	2019

Article

Year

Introduction of novel agents in the treatment of primary CNS lymphoma.

Neuro-oncology, 2019, 02-19, Volume: 21, Issue:3

Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Aminopyridines; Antineoplastic Agents, Immunological; Burkitt Lymphoma; Central Nervous System Neoplasms; Humans; Immunologic Factors; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Rituximab; Salvage Therapy; Thalidomide; Toll-Like Receptors; TOR Serine-Threonine Kinases; Tumor Escape

2019

Other Studies

1 other study(ies) available for pomalidomide and African Lymphoma

Article	Year
S-3-Amino-phthalimido-glutarimide inhibits angiogenesis and growth of B-cell neoplasias in mice. Cancer research, 2002, Apr-15, Volume: 62, Issue:8 Topics: 3T3 Cells; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Burkitt Lymphoma; Carcinoma, Lewis Lung; Cell Division; Growth Inhibitors; Humans; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Mice, SCID; Multiple Myeloma; Neovascularization, Physiologic; Thalidomide; Xenograft Model Antitumor Assays	2002

Article

Year

S-3-Amino-phthalimido-glutarimide inhibits angiogenesis and growth of B-cell neoplasias in mice.

Cancer research, 2002, Apr-15, Volume: 62, Issue:8

Topics: 3T3 Cells; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Burkitt Lymphoma; Carcinoma, Lewis Lung; Cell Division; Growth Inhibitors; Humans; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Mice, SCID; Multiple Myeloma; Neovascularization, Physiologic; Thalidomide; Xenograft Model Antitumor Assays

2002